Celldex Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $47.5M | $337.6M | $72.1M |
| FY2016 | $117.9M | $383.4M | $42.5M |
| FY2017 | $79.3M | $315.6M | $40.3M |
| FY2018 | $31.7M | $155.8M | $24.3M |
| FY2019 | $28.9M | $122.9M | $11.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $47.5M | $337.6M | $72.1M |
| FY2016 | $117.9M | $383.4M | $42.5M |
| FY2017 | $79.3M | $315.6M | $40.3M |
| FY2018 | $31.7M | $155.8M | $24.3M |
| FY2019 | $28.9M | $122.9M | $11.2M |